你即將離開本站

並前往https://www.marketscreener.com/quote/stock/GT-BIOPHARMA-INC-37507062/news/ESMO-Targeted-Anticancer-Therapies-Congress-Driving-NK-cell-immunotherapy-against-NSCLC-in-the-con-39714709/

Driving NK cell immunotherapy against NSCLC, in the context ...

Cross-linking CD16 and the tumor antigen drives cytotoxicity, and IL15 provides survival and proliferation signals to NK cells (B).

確定！ 回上一頁

查詢 「CD16」的人也找了：

  1. cd16+cd56
    2.
  2. cd16中文
    3.
  3. cd16 gene
    4.
  4. CD32
    5.
  5. CD56
    6.
  6. CD14
    7.
  7. CD16
    8.
  8. NKG2D
    9.